Insulin-induced attenuation of noradrenaline-mediated vasoconstriction in resistance arteries from Wistar rats is nitric oxide dependent

Clinical Science

Volumn 92, Issue 2, 1997, Pages 147-152

  Walker, A B ^a,b   Savage, M W ^a   Dores, J ^a   Williams, G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b WALTON HOSPITAL   (United Kingdom)

Author keywords

Insulin vasodilatation; Nitric oxide; Resistance arteries

Indexed keywords

ARGININE METHYL ESTER; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN;

ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 0031036887     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920147     Document Type: Article

References (36)

1. Page MMcB, Watkins PJ. Provocation of postural hypotension by insulin in diabetic neuropathy. Diabetes 1976; 25: 90-5.
2. Williams G, Pickup J, Clark A, Bowcock S, Cooke E, Keen H. Changes in blood flow close to subcutaneous insulin injection sites in stable and brittle diabetics. Diabetes 1983; 32: 466-73.
3. Walker AB, Dores J, Savage MW, Leese GP, Williams G. Prolonged exposure to high physiological insulin levels causes impaired maximal noradrenaline-induced vasoconstriction in resistance arteries [Abstract]. Diabet Med 1994; 11 (Suppl. 2): S28.
4. McNally PG, Lawrence IG, Watt PAC, Hillier C, Burden AC, Thurston H. The effect of insulin on the vascular reactivity of isolated resistance arteries taken from healthy volunteers. Diabetologia 1995; 38: 467-73.
5. Baron AD, Brechtel G, Johnson A, Henty D. Insulin (I) attenuates norepinephrine's (NE) pressor effect [Abstract]. Diabetes 1992; 41 (Suppl. 1): 125A.
6. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 1990; 85: 1844-52.
7. Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994; 267: E187-202.
8. Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992; 41: 1076-83.
9. Wu H-Y, Jeng YY, Yue C-J, Chyu K-Y, Hsueh WA, Chan TM. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes 1994; 43: 1027-32.
10. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
11. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-9.
12. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994; 94: 2511-15.
13. Mulvany MJ, Halpern W. Mechanical properties of smooth muscle cells in situ. Nature (London) 1976; 260: 617-19.
14. Taylor PD, McCarthy AL, Thomas CR, Poston L. Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br J Pharmacol 1992; 107: 393-9.
15. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive rats. Circ Res 1977; 41(1): 19-26.
16. Rees DD, Palmer RMJ, Schultz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-52.
17. Waldman SA, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 1988; 12 (Suppl. 5): S115-18.
18. 2-adrenergic receptors in response to insulin. J Biol Chem 1992; 267: 26017-22.
19. 2-adrenoceptors and endothelium-derived relaxing factor. Am J Med 1989; 87 (Suppl. 3C): 1-5S.
20. Goode GK, Heagerty AM. In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1995; 91: 2898-903.
21. Walker AB, Buckingham RE, Williams G. Impaired insulin-induced vasodilatation in insulin-resistant fatty Zucker rats: the basis of hypertension? [Abstract]. Diabetes 1995; 44 (Suppl. 1): 173A.
22. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7.
23. Panza JA, García CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1994; 91: 1732-8.
24. Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER. Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol 1989; 121: 101-6.
25. Haylor JH, Singh I, El Nahas AM. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int 1991; 39: 333-5.
26. Schini VB, Catovsky S, Schray-Utz B, Busse R, Vanhoutte PM. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Circ Res 1994; 74: 24-32.
27. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells: effects on cell proliferation. Circ Res 1992; 71: 1088-100.
28. Mollace V, Salvemini D, Anggard E, Vane J. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle guanylate cyclase. Br J Pharmacol 1991; 104: 633-8.
29. Tooke JE, Lins P-E, Östergren J, Adamson U, Fagrell B. The effects of intravenous insulin infusion on skin microcirculatory flow in Type I diabetes. Int J Microcirc Clin Exp 1985; 4: 69-83.
30. Wambach GK, Liu D. Insulin attenuates vasoconstriction induced by noradrenaline, serotonin and potassium chloride in rat mesenteric resistance arteries. J Hypertens 1991; 9 (Suppl. 6): S198-9.
31. Hjemdahl P. Plasma catecholamine determinations: analytical problems and interpretations. In: Christensen NJ, Henriksen O, Lassen NA, eds. The sympathoadrenal system. Physiology and pathophysiology. New York: Raven Press, 1986.
32. Goldfien A. Adrenal medulla. In: Greenspan FS, Baxter JD, eds. Basic and clinical endocrinology. Norwalk, CT, U.S.A.: Appleton & Lange, 1994.
33. Silverberg AB, Shah SD, Haymond MW, Cryer PE. Norepinephrine: Hormone and neurotransmitter in man. Am J Physiol 1978; 234: E252-6.
34. Buus NH, VanBavel E, Mulvany MJ. Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparations. Br J Pharmacol 1994; 112: 579-87.
35. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246-52.
36. Yagi S, Takata S, Kiyokawa H, Yamamoto M, Noto Y, Ikeda T, Hattori N. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 1988; 37: 1064-7.